Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Clarivate Plc CLVT

Clarivate Plc is a global provider of transformative intelligence. The Company offers enriched data, insights and analytics, workflow solutions and expert services in the areas of Academia & Government (A&G), Intellectual Property (IP) and Life Sciences & Healthcare (LS&H). Within the A&G segment, the Company provides research and analytics, content aggregation, and workflow software solutions.... see more

Recent & Breaking News (NYSE:CLVT)

Clarivate Reports Fourth Quarter and Full Year 2023 Results

PR Newswire February 27, 2024

Clarivate Recognized in the WTR 1000 2024 for Trademark Business

Canada NewsWire February 23, 2024

Clarivate Launches New Center for Intellectual Property and Innovation Research

PR Newswire February 20, 2024

Clarivate Partners with the Financial Times to Power its Business School Rankings

PR Newswire February 12, 2024

Clarivate Completes Refinancing of Term Loan and Revolver Extension

PR Newswire February 1, 2024

Clarivate Launches Web of Science Grants Index to Help Researchers Optimize Funding Strategies

PR Newswire January 29, 2024

Clarivate to Report Fourth Quarter and Full Year 2023 Results on February 27, 2024

PR Newswire January 24, 2024

Clarivate Announces Commencement of Term Loan Refinancing Transaction

PR Newswire January 22, 2024

Clarivate Identifies Thirteen Potential Blockbuster Drugs and Gamechangers in Annual Drugs to Watch Report

PR Newswire January 8, 2024

Clarivate Reveals Stronger Outlook for Pulsed-field Ablation Market and Potential for Device to Revolutionize Treatment Paradigm

Canada NewsWire December 19, 2023

Clarivate Expands Partnership with VeriSIM Life to Accelerate and De-risk Research and Drug Development

PR Newswire December 5, 2023

Clarivate Reveals World's Influential Researchers in Highly Cited Researchers 2023 List

PR Newswire November 15, 2023

Clarivate to Present at the RBC Capital Markets 2023 Technology, Internet, Media and Telecommunications Conference on November 14, 2023

PR Newswire November 8, 2023

Clarivate Reports Third Quarter 2023 Results

PR Newswire November 7, 2023

Clarivate Report Reveals China Challenging U.S. Research Dominance, Signaling Future Research Ambitions

PR Newswire October 31, 2023

Clarivate Partners with EveryLibrary to Support and Nurture Libraries in the U.S.

PR Newswire October 26, 2023

BioWorld by Clarivate Examines Impact of Emerging Medicines on Obesity

PR Newswire October 24, 2023

Clarivate Renews Partnership with The Federal Library and Information Network

PR Newswire October 18, 2023

Clarivate to Report Third Quarter 2023 Results on November 7, 2023

PR Newswire October 16, 2023

Clarivate Report Finds Significant Adoption of AI in IP

PR Newswire October 12, 2023